Top

Published in:

Open Access 01-12-2023 | Research

TRPA1 activation and Hsp90 inhibition synergistically downregulate macrophage activation and inflammatory responses in vitro

Authors: Anukrishna Radhakrishnan, Tathagata Mukherjee, Chandan Mahish, P Sanjai Kumar, Chandan Goswami, Subhasis Chattopadhyay

Published in: BMC Immunology | Issue 1/2023

Abstract

Background

Transient receptor potential ankyrin 1 (TRPA1) channels are known to be actively involved in various pathophysiological conditions, including neuronal inflammation, neuropathic pain, and various immunological responses. Heat shock protein 90 (Hsp90), a cytoplasmic molecular chaperone, is well-reported for various cellular and physiological processes. Hsp90 inhibition by various molecules has garnered importance for its therapeutic significance in the downregulation of inflammation and are proposed as anti-cancer drugs. However, the possible role of TRPA1 in the Hsp90-associated modulation of immune responses remains scanty.

Results

Here, we have investigated the role of TRPA1 in regulating the anti-inflammatory effect of Hsp90 inhibition via 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) in lipopolysaccharide (LPS) or phorbol 12-myristate 13-acetate (PMA) stimulation in RAW 264.7, a mouse macrophage cell lines and PMA differentiated THP-1, a human monocytic cell line similar to macrophages. Activation of TRPA1 with Allyl isothiocyanate (AITC) is observed to execute an anti-inflammatory role via augmenting Hsp90 inhibition-mediated anti-inflammatory responses towards LPS or PMA stimulation in macrophages, whereas inhibition of TRPA1 by 1,2,3,6-Tetrahydro-1,3-dimethyl-N-[4-(1-methylethyl)phenyl]-2,6-dioxo-7 H-purine-7-acetamide,2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7 H-purin-7-yl)-N-(4-isopropylphenyl)acetamide (HC-030031) downregulates these developments. LPS or PMA-induced macrophage activation was found to be regulated by TRPA1. The same was confirmed by studying the levels of activation markers (major histocompatibility complex II (MHCII), cluster of differentiation (CD) 80 (CD80), and CD86, pro-inflammatory cytokines (tumor necrosis factor (TNF) and interleukin 6 (IL-6)), NO (nitric oxide) production, differential expression of mitogen-activated protein kinase (MAPK) signaling pathways (p-p38 MAPK, phospho-extracellular signal-regulated kinase 1/2 (p-ERK 1/2), and phosphor-stress-activated protein kinase/c-Jun N-terminal kinase (p-SAPK/JNK)), and induction of apoptosis. Additionally, TRPA1 has been found to be an important contributor to intracellular calcium levels toward Hsp90 inhibition in LPS or PMA-stimulated macrophages.

Conclusion

This study indicates a significant role of TRPA1 in Hsp90 inhibition-mediated anti-inflammatory developments in LPS or PMA-stimulated macrophages. Activation of TRPA1 and inhibition of Hsp90 has synergistic roles towards regulating inflammatory responses associated with macrophages. The role of TRPA1 in Hsp90 inhibition-mediated modulation of macrophage responses may provide insights towards designing future novel therapeutic approaches to regulate various inflammatory responses.

Available only for authorised users

Flockerzi V, Bruford EA, Caterina MJ et al. For the superfamily of TRP cation channels the TRP superfamily includes a diversity of non-voltage-. 2002;9:229–31.

Ramsey I, Delling M, Clapham D. An introduction to TRP channels. Annu Rev Physiol. 2006;68:619–47. https://doi.org/10.1146/annurev.physiol.68.040204.100431CrossRefPubMed

Gaudet R. TRP channels entering the structural era. J Physiol. 2008;586(15):3565–75. https://doi.org/10.1113/jphysiol.2008.155812CrossRefPubMedPubMedCentral

Gees M, Colsoul B, Nilius B. The role of transient receptor potential cation channels in Ca2 + signaling. Cold Spring Harb Perspect Biol. 2010;2(10):a003962. https://doi.org/10.1101/cshperspect.a003962CrossRefPubMedPubMedCentral

Vay L, Gu C, Mcnaughton PA. The thermo-TRP ion channel family: properties and therapeutic implications. Published online. 2012. https://doi.org/10.1111/j.1476-5381.2011.01601.xCrossRef

Clapham DE. TRP channels as cellular sensor. Nature. 2003;426(December):517–24.CrossRefPubMed

Smani T, Shapovalov G, Skryma R, Prevarskaya N, Rosado JA. Biochimica et Biophysica Acta Functional and physiopathological implications of TRP channels. BBA - Mol Cell Res. 2015;1853(8):1772–82. https://doi.org/10.1016/j.bbamcr.2015.04.016CrossRef

Pla AF, Gkika D. Emerging role of TRP channels in cell migration: from tumor vascularization to metastasis. 2013;4(November):1–13. https://doi.org/10.3389/fphys.2013.00311

Sukumaran P, Schaar A, Sun Y, Singh BB. Functional role of TRP channels in modulating ER stress and autophagy. Cell Calcium Published online 2016:1–10. https://doi.org/10.1016/j.ceca.2016.02.012

10.

Montell C, Birnbaumer L, Flockerzi V, et al. A unified nomenclature for the superfamily of TRP cation channels. Mol Cell. 2002;9(2):229–31. https://doi.org/10.1016/s1097-2765(02)00448-3CrossRefPubMed

11.

Payrits M, Helyes Z, Szentagothai J, Sciences AE. Oestrogen-dependent up-regulation of TRPA1 and TRPV1 receptor proteins in the rat endometrium. 2015;(December):1–49.

12.

Tian C, Huang R, Tang F, et al. Transient receptor potential ankyrin 1 contributes to Lysophosphatidylcholine – Induced Intracellular Calcium Regulation and THP – 1 – derived macrophage activation. J Membr Biol. 2019;0123456789. https://doi.org/10.1007/s00232-019-00104-2

13.

Amraiz D, Zaidi N, us sahar S, Fatima M. Antiviral evaluation of an Hsp90 inhibitor, gedunin, against dengue virus. 2017;16(May):997–1004.

14.

Logu F, De, Nassini R, Materazzi S et al. Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice. Nat Commun Published online 1887:1–16. https://doi.org/10.1038/s41467-017-01739-2

15.

Facchinetti F, Amadei F, Geppetti P et al. A, b -Unsaturated aldehydes in cigarette smoke release Inflammatory Mediators from Human Macrophages. https://doi.org/10.1165/rcmb.2007-0130OC

16.

Sahoo SS, Majhi RK, Tiwari A, et al. Transient receptor potential ankyrin1 channel is endogenously expressed in T cells and is involved in immune functions. Biosci Rep. 2019;39(9):BSR20191437. https://doi.org/10.1042/BSR20191437CrossRefPubMedPubMedCentral

17.

Ma S, Zhang Y, He K, Wang P, Wang DH. Knockout of TRPA1 exacerbates angiotensin II-induced kidney injury.

18.

Zeng D, Chen C, Zhou W, et al. TRPA1 deficiency alleviates inflammation of atopic dermatitis by reducing macrophage infiltration. Life Sci. 2021;266:118906. https://doi.org/10.1016/j.lfs.2020.118906CrossRefPubMed

19.

Kun J, Szitter I, Kemény A, et al. Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles. PLoS ONE. 2014;9(9):e108164. https://doi.org/10.1371/journal.pone.0108164CrossRefPubMedPubMedCentral

20.

Ma S, Wang DH. Knockout of Trpa1 exacerbates renal ischemia-reperfusion injury with classical activation of macrophages. Am J Hypertens. Published online October 2020. https://doi.org/10.1093/ajh/hpaa162

21.

Usui-kusumoto K, Iwanishi H, Ichikawa K, et al. Suppression of neovascularization in corneal stroma in a TRPA1-null mouse. Exp Eye Res. 2019;181(February 2018):90–7. https://doi.org/10.1016/j.exer.2019.01.002CrossRefPubMed

22.

Shepherd AJ, Copits BA, Mickle AD, et al. Angiotensin II triggers peripheral macrophage-to-sensory Neuron Redox Crosstalk to Elicit Pain. J Neurosci. 2018;38(32):7032–57. https://doi.org/10.1523/JNEUROSCI.3542-17.2018CrossRefPubMedPubMedCentral

23.

Logu F, De, Prá SDtoé, De DCT, De et al. Macrophages and Schwann cell TRPA1 mediate chronic allodynia in a mouse model of complex regional pain syndrome type I. Brain Behav Immun. Published online 2020. https://doi.org/10.1016/j.bbi.2020.04.037

24.

Meseguer V, Alpizar YA, Luis E, et al. TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. Nat Commun. 2014;5:3125. https://doi.org/10.1038/ncomms4125CrossRefPubMed

25.

Yin S, Wang P, Xing R, et al. Transient receptor potential ankyrin 1 (TRPA1) mediates lipopolysaccharide (LPS)-Induced inflammatory responses in Primary Human Osteoarthritic Fibroblast-Like Synoviocytes. Inflammation. 2018;41(2):700–9. https://doi.org/10.1007/s10753-017-0724-0CrossRefPubMed

26.

Ko HK, Lin AH, Perng DW, Lee TS, Kou YR. Lung epithelial TRPA1 mediates Lipopolysaccharide-Induced Lung inflammation in bronchial epithelial cells and mice. Front Physiol. 2020;11. https://doi.org/10.3389/fphys.2020.596314

27.

Romano B, Borrelli F, Fasolino I, et al. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol. 2013;169(1):213–29. https://doi.org/10.1111/bph.12120CrossRefPubMedPubMedCentral

28.

Yusuf N, Nasti TH, Huang CM, et al. Heat shock proteins HSP27 and HSP70 are Present in the skin and are important mediators of allergic contact hypersensitivity. J Immunol. 2009;182(1):675–83. https://doi.org/10.4049/jimmunol.182.1.675CrossRefPubMed

29.

Atoyan R, Shander D, Botchkareva NV. Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J Invest Dermatol. 2009;129(9):2312–5. https://doi.org/10.1038/jid.2009.58CrossRefPubMed

30.

Cojocaru F, Şelescu T, Domocoş D, et al. Functional expression of the transient receptor potential ankyrin type 1 channel in pancreatic adenocarcinoma cells. Sci Rep. 2021;11(1):2018. https://doi.org/10.1038/s41598-021-81250-3CrossRefPubMedPubMedCentral

31.

Gouin O, L’Herondelle K, Lebonvallet N, et al. TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. Protein Cell. 2017;8(9):644–61. https://doi.org/10.1007/s13238-017-0395-5CrossRefPubMedPubMedCentral

32.

Prodromou C, Pearl LH. Structure and functional relationships of Hsp90. Curr Cancer Drug Targets. 2003;3(5):301–23. https://doi.org/10.2174/1568009033481877CrossRefPubMed

33.

Kamal A, Boehm MF, Burrows FJ. Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med. 2004;10(6):283–90. https://doi.org/10.1016/j.molmed.2004.04.006CrossRefPubMedPubMedCentral

34.

Srisutthisamphan K, Jirakanwisal K, Ramphan S, Tongluan N, Kuadkitkan A, Smith DR. Hsp90 interacts with multiple dengue virus 2 proteins. Sci Rep. 2018;8(1):4308. https://doi.org/10.1038/s41598-018-22639-5CrossRefPubMedPubMedCentral

35.

Geller R, Taguwa S, Frydman J. Broad action of Hsp90 as a host chaperone required for viral replication. Biochim Biophys Acta. 2012;1823(3):698–706. https://doi.org/10.1016/j.bbamcr.2011.11.007CrossRefPubMed

36.

Siebelt M, Jahr H, Groen HC, et al. Hsp90 inhibition protects against Biomechanically Induced Osteoarthritis in rats. Arthritis \& Rheum. 2013;65(8):2102–12. https://doi.org/10.1002/art.38000CrossRef

37.

Tukaj S, Węgrzyn G. Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress Chaperones. 2016;21(2):213–8. https://doi.org/10.1007/s12192-016-0670-zCrossRefPubMedPubMedCentral

38.

Moser C, Lang SA, Stoeltzing O. Heat-shock protein 90 (Hsp90) as a Molecular Target for Therapy of Gastrointestinal Cancer. Anticancer Res. 2009;29(6):2031–42. https://ar.iiarjournals.org/content/29/6/2031PubMed

39.

Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer. 2010;10(8):537–49. https://doi.org/10.1038/nrc2887CrossRefPubMedPubMedCentral

40.

Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol. 2002;2(3):185–94. https://doi.org/10.1038/nri749CrossRefPubMed

41.

Rice JW, Veal JM, Fadden RP, et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum. 2008;58(12):3765–75. https://doi.org/10.1002/art.24047CrossRefPubMed

42.

Wax S, Piecyk M, Maritim B, Anderson P. Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts. Arthritis Rheum. 2003;48(2):541–50. https://doi.org/10.1002/art.10780CrossRefPubMed

43.

Sugita T, Tanaka S, Murakami T, Miyoshi H, Ohnuki T. Immunosuppressive effects of the heat shock protein 90-binding antibiotic geldanamycin. Biochem Mol Biol Int. 1999;47(4):587–95. https://doi.org/10.1080/15216549900201633CrossRefPubMed

44.

Giannini A, Bijlmakers MJ. Regulation of the src family kinase lck by Hsp90 and ubiquitination. Mol Cell Biol. 2004;24(13):5667–76. https://doi.org/10.1128/MCB.24.13.5667-5676.2004CrossRefPubMedPubMedCentral

45.

Bijlmakers MJJE, Marsh M. Hsp90 is essential for the synthesis and subsequent membrane Association, but not the maintenance, of the src-kinase p56 lck. Mol Biol Cell. 2000;11(5):1585–95. https://doi.org/10.1091/mbc.11.5.1585CrossRefPubMedPubMedCentral

46.

J Biol Chem. 2005;280(11):9813–9822. doi:10.1074/jbc.M409745200.

47.

Poulaki V, Iliaki E, Mitsiades N, et al. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. FASEB J. 2007;21(9):2113–23. https://doi.org/10.1096/fj.06-7637comCrossRefPubMed

48.

Dello Russo C, Polak PE, Mercado PR, et al. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem. 2006;99(5):1351–62. https://doi.org/10.1111/j.1471-4159.2006.04221.xCrossRefPubMed

49.

Bautista DM, Pellegrino M, Tsunozaki M. TRPA1: a gatekeeper for inflammation. Annu Rev Physiol. 2013;75:181–200. https://doi.org/10.1146/annurev-physiol-030212-183811CrossRefPubMed

50.

Nagata K, Duggan A, Kumar G, Garcı J. Nociceptor and Hair Cell Transducer Properties of TRPA1, a Channel for Pain and hearing. 2005;25(16):4052–61. https://doi.org/10.1523/JNEUROSCI.0013-05.2005

51.

Bertin S, Aoki-nonaka Y, Lee J et al. The TRPA1 ion channel is expressed in CD4 + T cells and restrains T-cell-mediated colitis through inhibition of TRPV1. Published online 2016:1–13. https://doi.org/10.1136/gutjnl-2015-310710

52.

Engel MA, Leffler A, Niedermirtl F et al. TRPA1 and substance P mediate colitis in mice. Published online 2011:1346–58. https://doi.org/10.1053/j.gastro.2011.07.002

53.

Trevisan G, Benemei S, Materazzi S, et al. TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress. Brain. 2016;139(5):1361–77. https://doi.org/10.1093/brain/aww038CrossRefPubMed

54.

Parenti A, Logu F, De, Geppetti P, Benemei S. What is the evidence for the role of TRP channels in in fl ammatory and immune. 2016;16:953–69. https://doi.org/10.1111/bph.13392

55.

Khalil M, Alliger K, Weidinger C, et al. Functional role of transient receptor potential channels in Immune cells and Epithelia. Front Immunol. 2018;9:174. https://doi.org/10.3389/fimmu.2018.00174CrossRefPubMedPubMedCentral

56.

Nayak TK, Mamidi P, Kumar A, et al. Regulation of viral replication, apoptosis and pro-inflammatory responses by 17-aag during chikungunya virus infection in macrophages. Viruses. 2017;9(1). https://doi.org/10.3390/v9010003

57.

Eid SR, Crown ED, Moore EL, et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol Pain. 2008;4. https://doi.org/10.1186/1744-8069-4-48

58.

Hansted AK, Bhatt DK, Olesen J, Jensen LJ, Jansen-Olesen I. Effect of TRPA1 activator allyl isothiocyanate (AITC) on rat dural and pial arteries. Pharmacol Rep. 2019;71(4):565–72. https://doi.org/10.1016/j.pharep.2019.02.015CrossRefPubMed

59.

Scroggins BT, Neckers L. Just say NO: nitric oxide regulation of Hsp90. EMBO Rep. 2009;10(10):1093–4. https://doi.org/10.1038/embor.2009.212CrossRefPubMedPubMedCentral

60.

Beck R, Dejeans N, Glorieux C, et al. Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif. PLoS ONE. 2012;7(7):e40795–5. https://doi.org/10.1371/journal.pone.0040795CrossRefPubMedPubMedCentral

61.

Giustarini D, Rossi R, Milzani A, Dalle-Donne I. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol. 2008;440:361–80. https://doi.org/10.1016/S0076-6879(07)00823-3CrossRefPubMed

62.

Ambade A, Catalano D, Lim A, Mandrekar P. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice. Hepatology. 2012;55(5):1585–95. https://doi.org/10.1002/hep.24802CrossRefPubMed

63.

Lei W, Mullen N, McCarthy S, et al. Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. J Biol Chem. 2017;292(25):10414–28. https://doi.org/10.1074/jbc.M116.769489CrossRefPubMedPubMedCentral

64.

Fujita K, Otsuka T, Kawabata T, et al. Inhibitors of heat shock protein 90 augment endothelin–1–induced heat shock protein 27 through the SAPK/JNK signaling pathway in osteoblasts. Mol Med Rep Published online April. 2018;12. https://doi.org/10.3892/mmr.2018.8878

65.

Kim W, Tokuda H, Kawabata T, et al. Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: suppression of SAPK/JNK and p38 MAP kinase. Prostaglandins Other Lipid Mediat. 2019;143:106327. https://doi.org/10.1016/j.prostaglandins.2019.03.002CrossRefPubMed

66.

Subramanian C, Grogan PT, Wang T, et al. Novel C-terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self-renewal, and epithelial–mesenchymal transition. Mol Oncol. 2020;14(9):2058–68. https://doi.org/10.1002/1878-0261.12686CrossRefPubMedPubMedCentral

67.

Yin S, Zhang L, Ding L, et al. Transient receptor potential ankyrin 1 (trpa1) mediates il-1β-induced apoptosis in rat chondrocytes via calcium overload and mitochondrial dysfunction. J Inflamm. 2018;15(1):27. https://doi.org/10.1186/s12950-018-0204-9CrossRef

68.

de Souza Monteiro D, De Logu F, Adembri C, et al. TRPA1 mediates damage of the retina induced by ischemia and reperfusion in mice. Cell Death Dis. 2020;11(8):633. https://doi.org/10.1038/s41419-020-02863-6CrossRef

69.

70.

Hoffmann A, Kann O, Ohlemeyer C, Hanisch UK, Kettenmann H. Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J Neurosci. 2003;23(11):4410–9. https://doi.org/10.1523/JNEUROSCI.23-11-04410.2003CrossRefPubMedPubMedCentral

71.

Zhao J, Shyue S, kun, Kou YR, Lu T, min, Lee T. Transient receptor potential ankyrin 1 Channel involved in atherosclerosis and. Macrophage-Foam Cell Formation. 2016;12. https://doi.org/10.7150/ijbs.15229

72.

Billeter AT, Galbraith N, Walker S, et al. TRPA1 mediates the effects of hypothermia on the monocyte inflammatory response. Surgery. 2015;158(3):646–54. https://doi.org/10.1016/j.surg.2015.03.065CrossRefPubMed

73.

Kochukov MY, Mcnearney TA, Fu Y, Westlund KN, Westlund KN, Trp T. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. 2006;1043:424–33. https://doi.org/10.1152/ajpcell.00553.2005

74.

Romano B, Borrelli F, Fasolino I, et al. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates. Published online. 2013. https://doi.org/10.1111/bph.12120CrossRef

75.

Chang YY, Lu CW, Jean WH, Shieh JS, Lin TY. Phorbol myristate acetate induces differentiation of THP-1 cells in a nitric oxide-dependent manner. Nitric Oxide - Biol Chem. 2021;July 2020109–10. https://doi.org/10.1016/j.niox.2021.02.002

76.

Jones E, Adcock IM, Ahmed BY, Punchard NA. Modulation of LPS stimulated NF-kappaB mediated nitric oxide production by PKCε and JAK2 in RAW macrophages. J Inflamm. 2007;4:1–9. https://doi.org/10.1186/1476-9255-4-23CrossRef

77.

Bai G, Matsuba T, Niki T, Hattori T. Stimulation of THP-1 macrophages with LPS increased the production of osteopontin-encapsulating Exosome. Int J Mol Sci. 2020;21(22). https://doi.org/10.3390/ijms21228490

78.

Properties C, Properties T. Technical data sheet technical data sheet. Cell. 2005;123(May):98–9.

79.

Papaioannou NE, Voutsas IF, Samara P, Tsitsilonis OE. A flow cytometric approach for studying alterations in the cytoplasmic concentration of calcium ions in immune cells following stimulation with thymic peptides. Cell Immunol. 2016;302:32–40. https://doi.org/10.1016/j.cellimm.2016.01.004CrossRefPubMed

80.

Tripathi P, Tripathi P, Kashyap L, Singh V. The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol. 2007;51(3):443–52. https://doi.org/10.1111/j.1574-695X.2007.00329.xCrossRefPubMed

Title: TRPA1 activation and Hsp90 inhibition synergistically downregulate macrophage activation and inflammatory responses in vitro
Authors: Anukrishna Radhakrishnan
Tathagata Mukherjee
Chandan Mahish
P Sanjai Kumar
Chandan Goswami
Subhasis Chattopadhyay
Publication date: 01-12-2023
Publisher: BioMed Central
Published in: BMC Immunology / Issue 1/2023
Electronic ISSN: 1471-2172
DOI: https://doi.org/10.1186/s12865-023-00549-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Sec1 regulates intestinal mucosal immunity in a mouse model of inflammatory bowel disease

Assessment of autoantibodies in paediatric population with primary immunodeficiencies: a pilot study

Humoral immune response and changes in peritoneal cell populations in rats immunized against two Leptospira serovars; serovar patoc and serovar pyrogenes

The effect of serum origin on cytokines induced killer cell expansion and function

A survey of the adaptive immune genes of the polka-dot batfish Ogcocephalus cubifrons

The digestive system and autoimmunity

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage